SCHEMBL5149403

SCHEMBL5149403

O=C(O)CCCC(CCCC(=O)O)(C(=O)O)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.53
SLC22A6 Q4U2R8 2/20 0.53
TSHR P16473 5/20 0.50
NFKB1 P19838 2/20 0.50
PMP22 Q01453 1/20 0.50
CAMK2A Q9UQM7 1/20 0.46
HDAC11 Q96DB2 4/20 0.43
KMT2A Q03164 2/20 0.43
GABRR3 A8MPY1 1/20 0.43
GABRP O00591 1/20 0.43
GABRD O14764 1/20 0.43
HDAC3 O15379 1/20 0.43
GABBR2 O75899 1/20 0.43
CYP1A2 P05177 1/20 0.43
THRB P10828 1/20 0.43
GABRA1 P14867 1/20 0.43
GABRB1 P18505 1/20 0.43
GABRG2 P18507 1/20 0.43
GABRR1 P24046 1/20 0.43
GABRB3 P28472 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16421115 0.90 TSHR (0.60) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL4810549 0.82 LMNA (0.47) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL11468156 0.82 AKR1B1 (0.60) LMNASLC22A6TSHRHDAC11KMT2A
SCHEMBL16421113 0.82 GPR84 (0.67) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL9132408 0.82 AKR1B1 (0.54) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL16384725 0.80 GPR84 (0.68) LMNASLC22A6TSHRHDAC11KMT2A
SCHEMBL21168213 0.80 GPR84 (0.68) LMNASLC22A6TSHRHDAC11KMT2A
SCHEMBL16418480 0.80 TSHR (0.48) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL8202305 0.78 LMNA (0.53) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL1032545 0.78 LMNA (0.53) LMNASLC22A6TSHRNFKB1PMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070014727-A1 Contrast media for nuclear spin tomography with use of the overhauser effect BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-01-18 US disclosed
WO-2006087144-A2 CONTRAST AGENTS FOR NUCLEAR SPIN TOMOGRAPHY CARRIED OUT BY MEANS OF OVERHAUSER EFFECT SCHERING AKTIENGESELLSCHAFT (DE) 2006-08-24 WO disclosed